Molecular Determinants of liver sinusoidal endothelial cells for hepatic regeneration
肝窦内皮细胞肝再生的分子决定因素
基本信息
- 批准号:10682071
- 负责人:
- 金额:$ 46.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcetaminophenAdultAngiopoietin-2AnticoagulationBiochemicalBiophysicsBloodBlood VesselsCapillarityCardiovascular systemCell LineCell physiologyCellsCentral VeinCicatrixCirrhosisDevelopmentEGF geneEndothelial CellsFGF2 geneFLI1 Transcription FactorFibrosisFunctional disorderGATA4 geneHepatectomyHepaticHepatic arteryHepatocyteHomeostasisHumanImmuneImpairmentInflammation MediatorsInflammatoryInjuryKupffer CellsLiverLiver DysfunctionLiver RegenerationLiver diseasesMaintenanceMicrofluidic MicrochipsMolecularMorbidity - disease rateMusNatural regenerationNatureOrganOutcome StudyPartial HepatectomyPathogenesisPhenotypePhysiologicalPortal vein structureProceduresRecoveryResearchRoleSignal TransductionSpecific qualifier valueStressTestingTissuesVEGFA geneVascular Endothelial CellVascularizationVasomotorWNT2 geneconstitutive expressiondesignefficacious treatmentend stage liver diseasefactor Cfetalhealingliver functionliver injuryliver repairliver transplantationmortalityorgan repairpreventregeneration functionregenerativerepairedself assemblystellate cellstem cellstherapy developmenttranscription factor
项目摘要
ABSTRACT
End-stage liver disease is associated with morbidity and mortality often requiring a liver transplant. Dysfunction
and capillarization of liver sinusoidal endothelial cells (LSECs) could contribute to impaired hepatic repair and
cirrhosis. Thus, uncovering the mechanisms by which LSECs acquire their specialized functions to support
hepatic repair could enable the development of therapies for scar-free liver repair. We have shown that
activation of Id1 and Cxcr7 in LSECs induce angiocrine factors, that guide hepatic regeneration without
fibrosis. However, the mechanism by which LSECs acquire their pro-hepatic functions is unknown. We show
that while transcription factors (TFs) Fli1 and Erg dictate the vascular fate and homeostasis of LSECs (Gomez-
Salinero JM, et al, Nature Cardiovascular Research, 2022), induction of TF c-Maf specifies the phenotype and
regenerative functions of LSECs (Gomez-Salinero JM, et al, Cell Stem Cell, 2022). Induction of c-Maf in
generic human endothelial cells (ECs) switches on liver-specific LSEC signatures and angiocrine factors
supporting hepatocyte functionality. In mice in which c-Maf is deleted in adult ECs, recovery from CCl4 results
in fibrosis and LSECs regression to arterial cell fate. Thus, we hypothesize that maintenance of LSEC vascular
cell fate requires constitutive Fli1 or Erg expression, sustaining LSECs homeostatic functions. Induction of c-
Maf enforces specialized pro-regenerative functions and interactions of LSECs with hepatocytes, Kupffer and
stellate cells that prevents stress-induced LSEC arterialization promoting hepatic repair without fibrosis. To this
end, we have reprogrammed human generic ECs to an adaptable tubulogenic state. These Reset-Vascular
Endothelial Cells (R-VECs) self-assemble into a 3D vascular network, transporting human blood and arborizing
hepatocytes (Palikuqi B et al. Nature, 2020). The vascularized hepatic aggregates with stellate and Kupffer
cells within scalable and perfusable microfluidic devices establish a human Hepatic-on-VascularNet platform,
enabling study of physiologically adaptive cross-talk between human hepatocytes and LSECs. This
hypothesis will be tested by performing these Aims: Aim 1: Define the mechanism by which hierarchical Fli1
and Erg expression through c-Maf induction sustains specialization of LSECs at steady state, during hepatic
regeneration and after CCl4 induced liver injury. AIM 2: Uncover the contribution of c-Maf expressed in the
Kupffer cells that by enforcing and sustaining LSEC vascular attributes regulate hepatic homeostasis during
liver regeneration and CCl4 induced liver injury. AIM 3: Employ the human Hepatic-On-VascularNet platform to
uncover the mechanism by which c-Maf is induced functionally in human liver ECs to form specialized LSECs.
Determine whether human c-Maf induced LSECs (iLSECs) can restore hepatic regeneration. Specifically, the
role of infusing human iLSECs in restoring hepatic repair post-acetaminophen (APAP) injury without provoking
fibrosis will be assessed. These studies will uncover the molecular determinants of human LSECs and allow
strategies to employ iLSECs to sustain its pro-regenerative and anti-fibrotic attributes for liver repair.
摘要
终末期肝病与发病率和死亡率有关,通常需要肝移植。功能障碍
而肝窦内皮细胞(LSECs)的毛细血管化可能有助于受损的肝脏修复和
肝硬变。因此,揭示了LSEC获得其专门功能以支持
肝修复可以使无疤痕肝修复疗法的发展成为可能。我们已经证明了
在LSECs中Id1和CXCR7的激活诱导血管分泌因子,这些因子引导肝再生而不是
纤维化症。然而,LSECs获得其促肝功能的机制尚不清楚。我们展示了
转录因子(TF)FlI1和Erg决定LSECs的血管命运和动态平衡。
Salineo JM等人,自然心血管研究,2022),Tf c-Maf的诱导指定了表型和
LSECs的再生功能(Gomez-Salineo JM等,Cell Stem Cell,2022)。原癌基因c-Maf的诱导作用
通用人内皮细胞(ECs)开关肝脏特异性LSEC信号和血管分泌因子
支持肝细胞功能。在成年内皮细胞c-Maf缺失的小鼠中,从CCl4中恢复的结果
纤维化和LSECs回归到动脉细胞的命运。因此,我们假设LSEC血管的维持
细胞命运需要组成性的FLI1或ERG表达,维持LSECs的动态平衡功能。C-的诱导
MAF增强LSECs的特殊促再生功能以及与肝细胞、Kupffer和
星状细胞,防止应激诱导的LSEC动脉化,促进肝修复,无纤维化。对这件事
最后,我们对人类通用内皮细胞进行了重新编程,使其处于一种适应性强的小管生成状态。这些重置血管
血管内皮细胞(R-VECs)自组装成3D血管网络,运输人体血液和树枝
肝细胞(Palikuqi B et al.自然,2020)。带血管的肝星状和枯否集合体
可扩展和可灌流的微流控设备内的细胞建立了人类肝脏血管网平台,
能够研究人肝细胞和LSECs之间的生理适应性串扰。这
将通过执行以下目标来检验假设:目标1:定义层级FLI1
C-Maf诱导的ERG表达支持LSECs在稳定状态下的特化
再生和CCl4诱导的肝损伤后。目标2:揭示c-Maf在
Kupffer细胞通过强制和维持LSEC血管属性来调节肝脏的动态平衡
肝再生和CCl4诱导的肝损伤。目的3:利用人类肝血管网平台
揭示c-Maf在人肝内皮细胞中功能诱导形成特化LSECs的机制。
确定人c-Maf诱导的LSECs(ILSECs)是否能恢复肝再生。具体地说,
人iLSECs输注对扑热息痛(APAP)后肝损伤的修复作用
将对纤维化进行评估。这些研究将揭示人类LSEC的分子决定因素,并允许
利用iLSECs维持其促再生和抗肝纤维化的肝修复特性的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shahin Rafii其他文献
Blood flow forces liver growth
血流推动肝脏生长
- DOI:
10.1038/d41586-018-06741-2 - 发表时间:
2018-09-26 - 期刊:
- 影响因子:48.500
- 作者:
Sina Y. Rabbany;Shahin Rafii - 通讯作者:
Shahin Rafii
Shahin Rafii的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shahin Rafii', 18)}}的其他基金
Adaptable tissue-specific endothelial cells for organ regeneration
用于器官再生的适应性组织特异性内皮细胞
- 批准号:
10594461 - 财政年份:2020
- 资助金额:
$ 46.9万 - 项目类别:
Adaptable tissue-specific endothelial cells for organ regeneration
用于器官再生的适应性组织特异性内皮细胞
- 批准号:
9894491 - 财政年份:2020
- 资助金额:
$ 46.9万 - 项目类别:
Adaptable tissue-specific endothelial cells for organ regeneration
用于器官再生的适应性组织特异性内皮细胞
- 批准号:
10397474 - 财政年份:2020
- 资助金额:
$ 46.9万 - 项目类别:
Deciphering molecular determinants of vascular heterogeneity for organ repair
破译器官修复血管异质性的分子决定因素
- 批准号:
9115995 - 财政年份:2014
- 资助金额:
$ 46.9万 - 项目类别:
Deciphering molecular determinants of vascular heterogeneity for organ repair
破译器官修复血管异质性的分子决定因素
- 批准号:
9327054 - 财政年份:2014
- 资助金额:
$ 46.9万 - 项目类别:
Deciphering molecular determinants of vascular heterogeneity for organ repair
破译器官修复血管异质性的分子决定因素
- 批准号:
8932020 - 财政年份:2014
- 资助金额:
$ 46.9万 - 项目类别:
Identification of vascular-derived signals for alveolar lung repair
识别肺泡肺修复的血管源信号
- 批准号:
8708964 - 财政年份:2013
- 资助金额:
$ 46.9万 - 项目类别:
Identification of vascular-derived signals for alveolar lung repair
识别肺泡肺修复的血管源信号
- 批准号:
8563169 - 财政年份:2013
- 资助金额:
$ 46.9万 - 项目类别:
Identification of vascular-derived signals for alveolar lung repair
识别肺泡肺修复的血管源信号
- 批准号:
8856658 - 财政年份:2013
- 资助金额:
$ 46.9万 - 项目类别:
Identification of vascular inductive signals in liver regeneration
肝再生中血管诱导信号的识别
- 批准号:
8444425 - 财政年份:2012
- 资助金额:
$ 46.9万 - 项目类别:
相似国自然基金
SirT1在Acetaminophen诱发的药物性肝损伤中的作用及机制
- 批准号:81100281
- 批准年份:2011
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Diverging roles of EGFR and MET in acetaminophen-induced acute liver injury
EGFR 和 MET 在对乙酰氨基酚诱导的急性肝损伤中的不同作用
- 批准号:
10633557 - 财政年份:2023
- 资助金额:
$ 46.9万 - 项目类别:
Neurodevelopmental Effect of Acetaminophen Exposures
对乙酰氨基酚暴露对神经发育的影响
- 批准号:
10736409 - 财政年份:2023
- 资助金额:
$ 46.9万 - 项目类别:
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis
对乙酰氨基酚和抗坏血酸脓毒症试验中器官功能障碍和恢复的机制
- 批准号:
10502613 - 财政年份:2022
- 资助金额:
$ 46.9万 - 项目类别:
Maternal acetaminophen use and childhood cancer
母亲使用对乙酰氨基酚与儿童癌症
- 批准号:
10675108 - 财政年份:2022
- 资助金额:
$ 46.9万 - 项目类别:
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis
对乙酰氨基酚和抗坏血酸脓毒症试验中器官功能障碍和恢复的机制
- 批准号:
10644023 - 财政年份:2022
- 资助金额:
$ 46.9万 - 项目类别:
Pulmonary implications of perinatal acetaminophen exposure
围产期对乙酰氨基酚暴露对肺部的影响
- 批准号:
10593099 - 财政年份:2022
- 资助金额:
$ 46.9万 - 项目类别:
Intravenous acetaminophen after cardiac surgery (IVACS)
心脏手术后静脉注射对乙酰氨基酚 (IVACS)
- 批准号:
462410 - 财政年份:2022
- 资助金额:
$ 46.9万 - 项目类别:
Operating Grants
Pulmonary implications of perinatal acetaminophen exposure
围产期对乙酰氨基酚暴露对肺部的影响
- 批准号:
10755924 - 财政年份:2022
- 资助金额:
$ 46.9万 - 项目类别:
Effects of acetaminophen on prenatal brain development: an organoid model
对乙酰氨基酚对产前大脑发育的影响:类器官模型
- 批准号:
10684055 - 财政年份:2022
- 资助金额:
$ 46.9万 - 项目类别:
Maternal acetaminophen use and childhood cancer
母亲使用对乙酰氨基酚与儿童癌症
- 批准号:
10852089 - 财政年份:2022
- 资助金额:
$ 46.9万 - 项目类别: